Mesenchymal stromal cell therapy in ischemic heart disease
- 22 September 2016
- journal article
- review article
- Published by Taylor & Francis Ltd in Scandinavian Cardiovascular Journal
- Vol. 50 (5-6), 293-299
- https://doi.org/10.1080/14017431.2016.1210213
Abstract
Although, treatment of ischemic heart disease (IHD) has improved considerably within the last decades, it is still the main cause of death worldwide. Despite maximum treatment, many IHD patients suffer from refractory angina and heart failure, which severely limits their daily lives. Moreover, IHD is very costly for the health care system. Therefore, new treatment options and strategies are being researched intensely. Stem cell therapy to improve myocardial perfusion and stimulate growth of new cardiomyocytes could be a new way to go. Nevertheless, the results from clinical studies have varied considerably, probably due to the use of many different cell lines obtained from different tissues and the different patient populations. The present review will focus on treatment with the mesenchymal stromal cell from bone marrow and adipose tissue in animal and patients with acute and chronic IHD (CIHD).Keywords
This publication has 32 references indexed in Scilit:
- Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in Patients With Acute Myocardial Infarction Based on Individual Patient DataCirculation Research, 2015
- Intracoronary Transplantation of CD34+ Cells Is Associated With Improved Myocardial Perfusion in Patients With Nonischemic Dilated CardiomyopathyJournal of Cardiac Failure, 2015
- Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina — Final 3-year follow-upInternational Journal of Cardiology, 2013
- Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Direct Intramyocardial Mesenchymal Stromal Cell Injections in Patients with Severe Refractory Angina: One-Year Follow-UpCell Transplantation, 2013
- The Economics of Heart FailureHeart Failure Clinics, 2012
- Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trialEuroIntervention, 2012
- Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory anginaScandinavian Cardiovascular Journal, 2011
- Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome?EPMA Journal, 2011
- Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) TrialEuropean Heart Journal, 2009